top of page

Asia Pacific Stem Cell Therapy Market Size Analysis, Demand, and Forecast 2023 to 2031

Robert Hofmann

What is Stem Cell Therapy?

Stem cell therapy is a medical approach that involves the use of stem cells to treat or prevent various diseases and medical conditions. Stem cells are unique cells in the human body that have the remarkable ability to develop into different types of specialized cells with specific functions. This characteristic makes them valuable in regenerative medicine and potential treatments for a wide range of conditions.


Asia Pacific Stem Cell Therapy Market Size Overview:

Astute Analytica has released its latest research report, presenting a comprehensive examination of the worldwide Asia Pacific Stem Cell Therapy Market for the projected timeframe spanning from 2022 to 2031. The Asia Pacific stem cell therapy market is poised for substantial growth in the coming years, with a projected compound annual growth rate (CAGR) of 10.29% between 2023 and 2031. This growth is expected to drive the market value up to US$ 3,420.05 Mn by 2031, following a successful revenue performance of US$ 1,453.61 Mn in 2022. Secure Your Sample PDF Report to Gain a Deeper Understanding: https://www.astuteanalytica.com/request-sample/asia-pacific-stem-cell-therapy-market

Asia Pacific Stem Cell Therapy Market

Stem cell therapy involves the following key steps:


Harvesting: Stem cells are collected from a suitable source, such as bone marrow, adipose tissue, or other tissues, depending on the type of therapy.

Isolation and Processing: The harvested stem cells are processed and isolated in a laboratory to prepare them for therapeutic use.

Administration: The isolated stem cells are then reintroduced into the patient's body, typically through injection or infusion. The cells can be directed to the specific site or tissue that needs repair or regeneration.

Differentiation: Once inside the body, the stem cells can potentially differentiate into the specific cell types required to repair damaged or diseased tissue. This can include cells such as neurons, muscle cells, or blood cells.

Stem cell therapy has shown promise in treating a range of conditions, including certain types of cancer, autoimmune diseases, neurological disorders, heart disease, and orthopedic injuries. However, it is important to note that while some stem cell therapies have been proven effective and are widely used, others are still in the experimental stage and require further research and clinical trials to establish their safety and efficacy.


Top Key Players of the Asia Pacific Stem Cell Therapy Market

  • AlloSource

  • Anterogen Co. Ltd.

  • Arce Therapeutics

  • Astellas Pharma Inc

  • Biogend Therapeutics

  • Biorestorative Therapies Inc.

  • Brainstorm Cell Limited.

  • Cellular Biomedicine Group

  • CORESTEM

  • Fujifilm Holding Corporation

  • Holostem Terapie Avanzate Srl

  • JCR Pharmaceuticals Co. Ltd.

  • Kangstem Biotech

  • MEDIPOST Co. Ltd.

  • Mesoblast Ltd

  • Personalized Stem Cells

  • PELL Biotech Co., Ltd.

  • Pluristem Inc.

  • RTI Surgical

  • Sartorius AG

  • Sewon Cellontech

  • Smith+Nephew

  • STEMPEUTICS RESEARCH PVT LTD.

  • Takeda Pharmaceutical Company Limited

  • Vericel Corp

  • Other Prominent Players


Segmentation Overview of the Asia Pacific Stem Cell Therapy Market


The Asia Pacific stem cell therapy market is segmented based on therapy type, product, cell source, technology, application and end user. By Therapy Type segmented, the Asia Pacific stem cell therapy market is sub-segmented into:

  • Autologous Stem Cell Therapy

  • Allogeneic Stem Cell Therapy

By Product segment, the Asia Pacific stem cell therapy market is sub-segmented into:

  • Adult Stem Cells (ASCs)

  • Human Embryonic Stem Cells (HESCs)

  • Induced Pluripotent Stem Cells (iPSCs)

  • Very Small Embryonic Like Stem Cells

By Cell source segment, the Asia Pacific stem cell therapy market is sub-segmented into:

  • Adipose tissue derived MSCs

  • Bone marrow derived MSCs

  • Placental/umbilical cord derived MSCs

  • Other Cell Sources

By technology segment, the Asia Pacific stem cell therapy market is sub-segmented into:

  • Cell Acquisition

  • Cell Production

  • Cryopreservation

  • Expansion and Sub-Culture

By application segment, the Asia Pacific stem cell therapy market is sub-segmented into:

  • Musculoskeletal Disorders

  • Wounds and Injuries

  • Acute Graft-Versus-Host Disease (AGVHD)

  • Surgeries

  • Gastrointestinal Diseases

  • Cardiovascular Diseases

  • Inflammatory & Autoimmune Diseases

  • Neurological Disorders

  • Others

By end user segment, the Asia Pacific stem cell therapy market is sub-segmented into:

  • Hospitals

  • Research institutes

  • Surgical institutes

  • Others

By country, the Asia Pacific stem cell therapy market is sub-segmented into:

  • China

  • India

  • Japan

  • Australia & New Zealand

  • ASEAN

  • Taiwan

  • South Korea

  • Rest of Asia Pacific

Secure Your Sample PDF Report to Gain a Deeper Understanding: https://www.astuteanalytica.com/request-sample/asia-pacific-stem-cell-therapy-market About Astute Analytica: Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our demanding clients across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe. They call-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all became analyzed for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us. Get in touch with us Phone number: +18884296757 Email: sales@astuteanalytica.com Visit our website: https://www.astuteanalytica.com/ LinkedIn | Twitter | YouTube | Facebook Trending Research Reports:


Коментарі


Blog Astute

©2023 by Blog Astute. Proudly created with Wix.com

bottom of page